US 11827601
Heterocyclic NMDA antagonists
granted A61PA61P25/06A61P25/18
Quick answer
US patent 11827601 (Heterocyclic NMDA antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P25/06, A61P25/18, A61P25/28